BB BIOTECH AG · Schaffhausen Switzerland (Swiss: BIO)
Key BB BIOTECH AG Financials
| Company Type | Public -(Swiss: BIO) Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Sales (mil.) | $1.7 |
| Employees | 5 |
BB BIOTECH AG Income Statement
| Dec 10 | Dec 09 | Dec 08 | |
| Revenue | 1.7 | 52.3 | 69.9 |
| Cost of Goods Sold | -- | -- | -- |
| Gross Profit | 1.7 | 52.3 | 69.9 |
| Gross Profit Margin | -- | -- | -- |
| SG&A Expense | 5.3 | 5.7 | 6.8 |
| Depreciation & Amortization | -- | -- | -- |
| Operating Income | (155.5) | 41.5 | 43.0 |
| Operating Margin | -9270.8% | 79.3% | 61.5% |
| Nonoperating Income | -- | -- | -- |
| Nonoperating Expenses | -- | -- | -- |
| Income Before Taxes | (155.5) | 36.1 | 43.0 |
| Income Taxes | 0.1 | 0.8 | 0.1 |
| Net Income After Taxes | (155.6) | 35.3 | 42.9 |
| Continuing Operations | (155.6) | 35.3 | 42.9 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (155.6) | 35.3 | 42.9 |
| Total Net Income | (155.6) | 35.3 | 42.9 |
| Net Profit Margin | -9274.3% | 67.5% | 61.4% |
| Diluted EPS from Total Net Income | (9.85) | 2.13 | 2.42 |
| Dividends per Share | 3.93 | 1.73 | 0.85 |
All amounts in millions of US Dollars except per share amounts.
BB BIOTECH AG Balance Sheet
| Assets | Dec 10 | Dec 09 | Dec 08 |
| Current Assets | |||
| Cash | -- | -- | -- |
| Net Receivables | -- | -- | -- |
| Inventories | -- | -- | -- |
| Other Current Assets | -- | -- | -- |
| Total Current Assets | -- | -- | -- |
| Net Fixed Assets | -- | -- | 12.3 |
| Other Noncurrent Assets | 1,463.6 | 1,465.2 | 1,520.8 |
| Total Assets | 1,463.6 | 1,465.2 | 1,533.0 |
| Liabilities | Dec 10 | Dec 09 | Dec 08 |
| Current Liabilities | |||
| Accounts Payable | 1.5 | 2.5 | 0.0 |
| Short-Term Debt | -- | -- | -- |
| Other Current Liabilities | -- | -- | -- |
| Total Current Liabilities | -- | -- | -- |
| Long-Term Debt | -- | -- | -- |
| Other Noncurrent Liabilities | 151.1 | 4.5 | 108.3 |
| Total Liabilities | 151.1 | 4.5 | 108.3 |
| Shareholder's Equity | |||
| Preferred Stock Equity | -- | -- | -- |
| Common Stock Equity | 1,312.5 | 1,460.7 | 1,424.8 |
| Total Equity | 1,312.5 | 1,460.7 | 1,424.8 |
| Shares Outstanding (thou.) | 15,240.0 | 16,413.8 | 20,250.0 |
All amounts in millions of US Dollars except per share amounts.
BB BIOTECH AG Cash Flow Statement
| Dec 10 | Dec 09 | Dec 08 | |
| Net Operating Cash Flow | (25) | 162 | 482 |
| Net Investing Cash Flow | -- | 0.0 | -- |
| Net Financing Cash Flow | 5.7 | (132.0) | (477.6) |
| Net Change in Cash | (22.3) | 30.8 | 1.5 |
| Depreciation & Amortization | |||
| Capital Expenditures | |||
| Cash Dividends Paid | (63.2) | (28.6) | (15.6) |
All amounts in millions of US Dollars except per share amounts.